For more information

on this study please

call +1 877-379-3718

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.

Study ID

208129/022

Study Title Study comparing immunogenicity, reactogenicity and safety of GSK Biologicals' HBV-MPL vaccine with that of Engerix™-B when both are injected according to 3 dose schedule (0, 1, 6 months) in an adult population aged between 50 and 70 years
Clinicaltrials.gov Identifier NCT00696891
Sponsor GlaxoSmithKline
Collaborators N/A
Study Recruitment Status Completed
Generic Name Hepatitis B Vaccine, Recombinant
Trade Name
Study Indication